Bookmark Kaumudi Online  Bookmark this site  Editor@Kaumudi  |  Marketing  Print Advt rates  |  Calendar 2012        Go!    
July 27, Sunday 2014 12:43 AM       
       HEADLINES: Hima Shankar to approach human rights panel against police ‘harassment’                                              Policeman killed in grenade attack in Sopore                                              Situation on LAC peaceful: Army                                              Uttar Pradesh: curfew in Saharanpur, two dead, several vehicles torched                                              AG view on LoP issue given to 'please political masters': Cong                                              Israel and Hamas declare 12-hour Gaza truce; death toll at 884                                              US Congressman mistakes Obama officials for Indian babus                                              Swaraj meets Nepalese counterpart; discusses a range of issues                                              Gaza death toll mounts to 940 amid fragile 12-hour truce                                              Canada's Bezzoubenko wins five golds in Glasgow                                              CWG: Judokas Pathania, Parikshit in quarters; Avtar out                                              Apurvi bags gold, shooters give three more medals                                              Kaumudi Facebook
       BUSINESS Next Article: SBI mulls selling bad assets to ARCs in Jan-Mar quarter  
       Ranbaxy recalls over 64,000 bottles of generic Lipitor in US
         Posted on :22:10:56 Mar 8, 2014
       Last edited on:22:10:56 Mar 8, 2014
         Tags: Ranbaxy, Lipitor in US

NEW DELHI: Drug major Ranbaxy Laboratories has recalled over 64,000 bottles of Atorvastatin calcium tablets, a generic version of cholesterol-lowering drug Lipitor, after a complaint of wrong dosage.

The Indian firm, which is reeling under regulatory action from the US Food and Drug Administration (USFDA), recalled the drug after a complaint by a pharmacist who discovered a 20 mg tablet inside a sealed bottle of Atorvastatin 10 mg tablets.

"Ranbaxy Pharmaceuticals is conducting a voluntary recall in the US limited to two lots of Atorvastatin calcium tablets, 10 mg manufactured in India which expire in May 2014," it said in a statement.

The company, majority owned by Japan's Daiichi Sankyo, said it recalled the tablets "because of a remote possibility of the presence of a 20 mg Atorvastatin calcium tablet in a 10 mg bottle."

"This is the basis of the voluntary recall," it added.

To date, Ranbaxy has not received any product complaints related to these batches, the company said.

"Other lot numbers, package sizes and strengths are not affected by this recall. The recall is being conducted at the retail level," it added.

Ranbaxy is withdrawing the lots out of abundant caution, keeping the safety of patients in mind and with full knowledge of the USFDA, it said.

In January, the USFDA prohibited Ranbaxy from producing and distributing drugs for the American market from its Toansa facility in Punjab.

The Toansa plant catered to over 70 per cent of Ranbaxy's requirement for raw material used in medicine formulations. Toansa was the fourth Ranbaxy plant banned by the USFDA.

In September, the USFDA imposed an import alert on Ranbaxy's Mohali plant in Punjab for violating good manufacturing norms.

Ranbaxy's key facilities at Paonta Sahib in Himachal Pradesh and Dewas in Madhya Pradesh have been under a US import alert since 2008.

Next Article: SBI mulls selling bad assets to ARCs in Jan-Mar quarter
Modi meets infra secretaries to set target for current fiscal  
Tremendous mood swing, positivity on Modi govt: Indian CEOs  
Marginal relief to MFs; new tax rate effective from Jul 10  
Tomato prices skyrocket to Rs 80 per kg in some cities  
Jet Airways appoints new management team  
'Indian IT industry faces gender pay gap of 29%'  
'Conflicting signals coming on India's stand on WTO Agreement'  
Sensex up 133 points; Nifty regains 7,800-mark  
Over Rs 5,840 loss for Indian airline industry in 2012-13:Govt  
Need more clarity on REITs' taxation: Parekh  
Incipient recovery on anvil for India: SBI  
Air India resumes Delhi-Moscow flight service after 15 years  
Revenue collection expected to exceed target this fiscal: FM  
SAIL,RINL spend Rs 7,000 cr for plants' maintenance in 3 years  
Sun Pharma-Ranbaxy deal gets BSE, NSE clearance  
Draft Cab note for govt stake dilution in SBI nxt month:Sandhu  
Forbes publisher sold to Asian investors  
Wipro inks $1.1bn IT deal with ATCO;acquires IT arm for $195mn  
IT shares lift Sensex to nearly two-week highs  
Google's Chief Business Officer Nikesh Arora leaving company  
Microsoft to axe 18,000 jobs globally; India impact minimal  
Sensex closes at over 1-week high; Hindalco logs best gain  
Nissan CEO: Japan female bosses goal too ambitious  
BRICS bank to get going in 2 yrs; India to head for 6 yrs  
Tata Comm to invest $200 mn to double data centres in India  
Do you think that there was corruption in Plus Two allotment?
Don't know
Home Kerala India World Business Sports Sci&Tech Education Automobile CityNews Movies Environment Letters 
© Copyright keralakaumudi Online 2011  |  Reproduction in whole or in part without written permission is prohibited.
Head Office Address: Kaumudi Buildings, Pettah P.O, Trivandrum - 695024, India.
Online queries talk to Deepu Sasidharan, + 91 98472 38959 or Email deepu[at]
Customer Service -Advertisement Disclaimer Statement   |  Copyright Policy